Drugs /

dendritic cell tumor cell lysate vaccine

Back to Drugs List

Overview

NCI Definition [1]:
A vaccine composed of dendritic cells pulsed with tumor cells lysates that stimulate a potent and specific cell mediated anti-tumor immune response. (NCI)

Clinical Trials

View Clinical Trials for dendritic cell tumor cell lysate vaccine

Dendritic cell tumor cell lysate vaccine has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating dendritic cell tumor cell lysate vaccine, 1 is phase 1 (1 open).

Glioblastoma is the most common disease being investigated in dendritic cell tumor cell lysate vaccine clinical trials [2].

Drug Details

Synonyms [2]:
dendritic cell-pulsed tumor cell lysate vaccine, dc tumor cell lysate vaccine, atl-dc
NCIT ID [1]:
C1988

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.